FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA, DoJ Expanding Enforcement Across Healthcare Ecosystem, Attorney Says

[ Price : $8.95]

In a mid-year enforcement update, Arnold Golden Gregory partner Gabriel Scannapieco says FDA and the Department of Justice are inc...

Opinion Piece Praises Diamantas' Vision for FDA Modernization

[ Price : $8.95]

A 7/20 opinion article contends that FDA acting commissioner Kyle Diamantas has outlined a broad vision for modernizing FDA by emp...

FDA Issues Early Alert on Baxter IV Administration Sets

[ Price : $8.95]

FDA issues an Early Alert warning healthcare providers about a potentially high-risk issue involving certain Baxter Duo-Vent solut...

China Surpasses U.S. in Novel Cancer Drug Approvals Since 2023: Analysis

[ Price : $8.95]

China approves more novel oncology drugs than the U.S. between 2020 and 2025, with its annual approval totals surpassing FDAs begi...

Dyne Therapeutics BLA for Duchenne Muscular Dystrophy

[ Price : $8.95]

FDA accepts for priority review a Dyne Therapeutics BLA for zeleciment rostudirsen for treating individuals with Duchenne muscular...

Nevada Man Pleads Guilty to Importing and Selling Misbranded Drugs

[ Price : $8.95]

A Nevada businessman enters guilty plea to importing and distributing misbranded prescription erectile dysfunction drugs from Indi...

Study Finds Compounded GLP-1 Market Remains Strong Despite FDA Crackdown

[ Price : $8.95]

A new study published in JAMA Health Forum suggests the market for compounded GLP-1 weight-loss drugs remains robust despite the F...

FDA Cites Charles River Endosafe Lab Over Quality System Deficiencies

[ Price : $8.95]

FDA issues a Form-483 to Charles River Laboratories' Endosafe contract testing laboratory in Charleston, SC, over multiple quality...

Friendly Accelerated Approval Disclosures Improve Drug Understanding: Study

[ Price : $8.95]

A new study suggests that direct-to-consumer prescription drug Web sites may better communicate the limitations of FDA accelerated...

Fujifilm Diosynth Cited Over NC Plants Microbial Contamination Controls

[ Price : $8.95]

FDA cites Fujifilm Diosynth Biotechnologies USA for significant manufacturing deficiencies at its drug substance facility in Resea...